Nationwide Fund Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-74,833	Closed	-$920K	–	1187
2017 Q3	$920K	Sell	74,833 -1,914	-2%	-$28.3K	﹤0.01%	1847
2017 Q2	$1.26M	Buy	76,747 +3,289	+4%	+$50.9K	0.01%	1651
2017 Q1	$1.05M	Sell	73,458 -232	-0.3%	-$3.44K	﹤0.01%	1720
2016 Q4	$1.02M	Sell	73,690 -3,701	-5%	-$59.4K	﹤0.01%	1769
2016 Q3	$1.4M	Sell	77,391 -3,300	-4%	-$53.1K	0.01%	1578
2016 Q2	$1.16M	Sell	80,691 -15,950	-17%	-$216K	0.01%	1639
2016 Q1	$1M	Sell	96,641 -43,235	-31%	-$453K	﹤0.01%	1724
2015 Q4	$1.86M	Buy	139,876 +77,446	+124%	+$952K	0.01%	1392
2015 Q3	$670K	Buy	62,430 +35,898	+135%	+$392K	﹤0.01%	1935
2015 Q2	$214K	Buy	26,532 +459	+2%	+$3.37K	﹤0.01%	2676
2015 Q1	$172K	Sell	26,073 -863	-3%	-$5.89K	﹤0.01%	2768
2014 Q4	$172K	Buy	26,936 +1,630	+6%	+$13.1K	﹤0.01%	2707
2014 Q3	$250K	Buy	25,306 +187	+0.7%	+$2K	﹤0.01%	2588
2014 Q2	$283K	Buy	25,119 +101	+0.4%	+$1.08K	﹤0.01%	2569
2014 Q1	$303K	Hold	25,018	–	–	﹤0.01%	2303
2013 Q4	$315K	Sell	25,018 -804	-3%	-$12.8K	﹤0.01%	2462
2013 Q3	$428K	Buy	25,822 +2,261	+10%	+$37.9K	﹤0.01%	2304
2013 Q2	$358K	Buy	+23,561	New	+$358K	﹤0.01%	2193